Cargando…
PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma
BACKGROUND: The diagnosis of AITL is challenging. It may be delayed or even missed due to critical clinical conditions and its histologic and immunophenotypic overlap with other neoplastic and reactive lymphoid proliferations. OBJECTIVE: The key objective is to obtain an efficient diagnosis, sensiti...
Autores principales: | Wang, Chunyan, Zhu, Li, Liu, Songya, Yi, Shujuan, Xiao, Min, Zhang, Yicheng, Mao, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492947/ https://www.ncbi.nlm.nih.gov/pubmed/36160159 http://dx.doi.org/10.3389/fmed.2022.962428 |
Ejemplares similares
-
The Early Diagnostic Dilemma in Angioimmunoblastic T Cell Lymphoma with Excessive Plasma Cells Proliferation
por: Wang, Chunyan, et al.
Publicado: (2021) -
Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies’ Recognition of TRBC1 and TRBC2
por: Zeng, Xincheng, et al.
Publicado: (2023) -
Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1
por: Saetang, Jirakrit, et al.
Publicado: (2022) -
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies
por: Zhang, Chaoting, et al.
Publicado: (2020) -
Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease
por: Tiemann, Markus, et al.
Publicado: (2020)